“We postulate that these observations may provide novel opportunities for therapeutic interventions for EGFR driven cancers.” “We postulate that BUB1 helps in the formation and stabilization of EGFR ...

Final results of randomized study of gemcitabine (G) plus cisplatin (P) versus etoposide (E) plus cisplatin in locally advanced or metastatic non small cell lung cancer (NSCLC) No significant ...

The most significant eGFR declines were seen in individuals who had short weekday sleep duration and long weekend sleep duration. A longer weekend sleep duration was associated with reduced estimated ...

Phase II study of bevacizumab in combination with S-1 plus cisplatin in patients with advanced nonsquamous non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2012 ASCO Annual ...

Real-world treatment of diabetic kidney disease in the United States, based on national-level health care claims and electronic health records data, is inconsistent with the current guidelines.